Option Care Health, Inc. (NASDAQ:OPCH) Stock Position Decreased by US Bancorp DE

US Bancorp DE cut its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 4.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,806 shares of the company’s stock after selling 373 shares during the quarter. US Bancorp DE’s holdings in Option Care Health were worth $181,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. UMB Bank n.a. boosted its stake in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after acquiring an additional 346 shares in the last quarter. Quarry LP boosted its position in shares of Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after buying an additional 2,628 shares during the period. Blue Trust Inc. boosted its position in shares of Option Care Health by 16.9% in the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock worth $109,000 after buying an additional 681 shares during the period. Venturi Wealth Management LLC boosted its position in shares of Option Care Health by 2,621.3% in the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock worth $110,000 after buying an additional 4,561 shares during the period. Finally, KBC Group NV boosted its position in shares of Option Care Health by 16.2% in the third quarter. KBC Group NV now owns 5,013 shares of the company’s stock worth $157,000 after buying an additional 700 shares during the period. 98.05% of the stock is owned by institutional investors.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $32.66 on Friday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $34.85. The business has a fifty day simple moving average of $30.81 and a 200 day simple moving average of $28.24. The firm has a market cap of $5.40 billion, a price-to-earnings ratio of 27.45, a P/E/G ratio of 2.30 and a beta of 1.33.

Analyst Ratings Changes

OPCH has been the subject of several recent analyst reports. Barrington Research raised their target price on Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. JPMorgan Chase & Co. raised their target price on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and raised their target price for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, JMP Securities reiterated a “market outperform” rating and set a $30.00 price objective (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and a consensus target price of $33.00.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.